Coverage
-
May 18, 2023
Lawyers for a whistleblower and Janssen Biotech sparred Thursday over whether three old lawsuits sink their current kickbacks and false claims case, with a Boston federal judge trying to nail down whether the earlier actions put the government on notice of the alleged fraud.
4 other articles on this case.
View all »